Skip to main content
Clinical Trials/NCT03077932
NCT03077932
Completed
Not Applicable

A Smartphone App to Facilitate Buprenorphine Discontinuation

Butler Hospital1 site in 1 country15 target enrollmentApril 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opiate Use Disorder
Sponsor
Butler Hospital
Enrollment
15
Locations
1
Primary Endpoint
Opiate use
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The investigators propose to develop a smartphone app (called BetterOFF) that will help patients manage opioid withdrawal during opioid medication taper and detoxification. The BetterOFF smartphone intervention will be a resource patients can access anytime and anywhere. If the BetterOFF intervention were to be effective in helping patients discontinue opioid medication, it could be integrated into the standard of care of office-based clinical practices, as well as substance use programs, thereby having a substantial public health impact.

Detailed Description

Many of the growing number of patients prescribed long-term opioid medication (for a variety of reasons including a history of illicit opioid use or management of chronic pain) will express an interest in discontinuing medication. However, many patients, physically dependent on opioids, fear the withdrawal symptoms that inevitably occur with opioid medication discontinuation and will experience a decrease in their self-efficacy for abstinence at the end of a taper. As a result, tapering is often slow and done hesitantly, and relapse rates after an opioid taper are high and associated with broad consequences, including significant negative physical, mental, and social problems. Even with optimal tapering protocols, patients need novel approaches to manage the discontinuation of opiate agonist treatment. Given this important gap in opioid treatment delivery, we propose to develop a theoretically-driven, smartphone-delivered intervention (Better Off app) to help patients effectively manage the experience of opioid medication discontinuation.

Registry
clinicaltrials.gov
Start Date
April 1, 2016
End Date
June 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • between 18-65 years of age;
  • currently receiving opioid medication;
  • interesting in discontinuing opioid medication
  • has a smartphone

Exclusion Criteria

  • non-English speaking.

Outcomes

Primary Outcomes

Opiate use

Time Frame: 1 month post-taper

Days of opiate use at follow-up

Secondary Outcomes

  • Fear of withdrawal symptoms(1 month post-taper)
  • Opiate Withdrawal(Baseline to 1 month post-taper)

Study Sites (1)

Loading locations...

Similar Trials